GET THE APP
Vaccine Peer-review Journals | Open Access Journals
Journal of Clinical Case Reports

Journal of Clinical Case Reports

ISSN: 2165-7920

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Vaccine Peer-review Journals

A vaccine is a biological preparation that gives active immunity to a particular disease. A vaccine usually contains an agent that resembles a pathogenic microorganism and is often made from weakened or killed forms of the microbe, its toxins being one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a blackmail, to destroy it and to keep track of it, so that the immune system can more easily recognize and destroy one of these microorganisms than 'he meets later.

Emerging practices and experiences in this area require critical and in-depth discussion to disseminate knowledge so that researchers can adopt them to pass the benefits on to the needy. The Journal of Vaccines & Vaccination accepts articles in the form of research articles, review articles, short communications, letters to editors, comments, case reports, etc. This vaccine journal is an open access scientific journal dedicated to the distribution of valuable information for benefit society.

Articles published in this journal go through a rigorous review and editing process before being accepted for publication, in order to maintain the quality and standards established for academic journals. The Vaccine Journal impact factor is reportedly 2.32 from the past five years.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 1345

Journal of Clinical Case Reports received 1345 citations as per Google Scholar report

Citation image
Journal of Clinical Case Reports peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature
 

Open Access Journals

arrow_upward arrow_upward